Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare

>>

Global Human Insulin Market


Global Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Report code: SDMRHE847781 | Industry: Healthcare | Published On: 1/18/2020


Global human insulin market is expected to reach $53.16 billion by 2026, representing a 2019-2026 CAGR of 7.47%.
Highlighted with 83 tables and 87 figures, this 161-page report “Global Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global human insulin market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global human insulin market in every aspect of the classification from perspectives of Product Type, Application, Distribution Channel, and Region.
Based on product type, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Human Insulin Drugs
• Human Insulin Delivery Devices
Based on product, the global Human Insulin Drugs market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Modern Human Insulin (further segmented into Long-acting, Rapid- acting, Premixed by type; further segmented into Lantus, Apidra, Levemir, NovoRapid/ NovoLog, Novomix, Humalog, Others by brand)
• Traditional Human Insulin (further segmented into Short-acting, Intermediate & Rapid-acting, Premixed by type; further segmented into Humulin, Insuman, Novolin/Actrapid/Insulatard by brand)
Based on product, the global Human Insulin Delivery Devices market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Syringes
• Pens (further segmented into Disposable, Reusable, Pen needles)
• Pumps
• Others
Based on application, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes and Prediabetes
Based on distribution channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Rest of Europe; Rest of Europe is further segmented into Russia, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S. and Canada)
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
• RoW (Saudi Arabia, UAE, South Africa)
For each of the aforementioned regions and countries, market analysis and revenue data are available for 2019-2026. The breakdown of all regional markets by country and split of major national markets by Product Type, Application, and Distribution Channel over the study years (2019-2026) are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global human insulin market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players:
Astra Zeneca PLC
Biocon
Eli Lilly
Exir
Julphar
Novo Nordisk AS
Pfizer
Sanofi Aventis
Sedico
Wockhardt
(Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 8
1.1  Industry  Definition  and  Research  Scope 8
1.1.1  Industry  Definition 8
1.1.2  Research  Scope 9
1.2  Research  Methodology 11
1.2.1  Overview  of  Market  Research  Methodology 11
1.2.2  Market  Assumption 12
1.2.3  Secondary  Data 12
1.2.4  Primary  Data 12
1.2.5  Data  Filtration  and  Model  Design 13
1.2.6  Market  Size/Share  Estimation 14
1.2.7  Research  Limitations 15
1.3  Executive  Summary 16
2  Market  Overview  and  Dynamics 18
2.1  Market  Size  and  Forecast 18
2.2  Major  Growth  Drivers 19
2.3  Market  Restraints  and  Challenges 22
2.4  Emerging  Opportunities  and  Market  Trends 25
2.5  Porter’s  Fiver  Forces  Analysis 28
3  Segmentation  of  Global  Market  by  Product  Type 32
3.1  Market  Overview  by  Product  Type 32
3.2  Human  Insulin  Drugs 34
3.3  Human  Insulin  Delivery  Devices 35
4  Segmentation  of  Global  Human  Insulin  Drugs  Market  by  Drug  Product 36
4.1  Market  Overview  by  Drug  Product 36
4.2  Modern  Human  Insulin 38
4.2.1  Modern  Human  Insulin  by  Type 40
4.2.2  Modern  Human  Insulin  by  Brand 43
4.3  Traditional  Human  Insulin 50
4.3.1  Traditional  Human  Insulin  by  Type 52
4.3.2  Traditional  Human  Insulin  by  Brand 55
5  Segmentation  of  Global  Human  Insulin  Delivery  Devices  Market  by  Device  Product 58
5.1  Market  Overview  by  Product 58
5.2  Syringes 60
5.3  Pens 61
5.4  Pumps 62
5.5  Other  Devices 63
6  Segmentation  of  Global  Market  by  Application 64
6.1  Market  Overview  by  Application 64
6.2  Type  1  Diabetes 66
6.3  Type  2  Diabetes 67
6.4  Gestational  Diabetes  and  Prediabetes 68
7  Segmentation  of  Global  Market  by  Distribution  Channel 69
7.1  Market  Overview  by  Distribution  Channel 69
7.2  Hospital  Pharmacies 71
7.3  Retail  Pharmacies 72
7.4  Online  Pharmacies 73
8  Segmentation  of  Global  Market  by  Region 74
8.1  Geographic  Market  Overview  2019-2026 74
8.2  North  America  Market  2019-2026  by  Country 78
8.2.1  Overview  of  North  America  Market 78
8.2.2  U.S.  Market 81
8.2.3  Canadian  Market 85
8.3  European  Market  2019-2026  by  Country 87
8.3.1  Overview  of  European  Market 87
8.3.2  Germany 90
8.3.3  UK 92
8.3.4  France 94
8.3.5  Spain 96
8.3.6  Italy 98
8.3.7  Rest  of  European  Market 100
8.4  Asia-Pacific  Market  2019-2026  by  Country 102
8.4.1  Overview  of  Asia-Pacific  Market 102
8.4.2  Japan 105
8.4.3  China 108
8.4.4  Australia 110
8.4.5  India 112
8.4.6  South  Korea 114
8.4.7  Rest  of  APAC  Region 116
8.5  Latin  America  Market  2019-2026  by  Country 118
8.5.1  Argentina 121
8.5.2  Brazil 123
8.5.3  Mexico 125
8.5.4  Rest  of  Latin  America  Market 127
8.6  Rest  of  World  Market  2019-2026  by  Country 128
8.6.1  UAE 131
8.6.2  Saudi  Arabia 133
8.6.3  South  Africa 135
8.6.4  Other  National  Markets 137
9  Competitive  Landscape 138
9.1  Overview  of  Key  Vendors 138
9.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 142
9.3  Company  Profiles 144
Astra  Zeneca  PLC 144
Biocon 146
Eli  Lilly 147
Exir 148
Julphar 149
Novo  Nordisk  AS 150
Pfizer 151
Sanofi  Aventis 152
Sedico 153
Wockhardt 154
10  Investing  in  Global  Market:  Risk  Assessment  and  Management 155
10.1  Risk  Evaluation  of  Global  Market 155
10.2  Critical  Success  Factors  (CSFs) 158
Related  Reports  and  Products 161
Table 1. Snapshot of Global Human Insulin Market, 2019-2026 17
Table 2. Main Product Trends and Market Opportunities in Global Human Insulin Market 25
Table 3. Global Human Insulin Market by Product Type, 2019-2026, $ mn 32
Table 4. Global Human Insulin Drugs Market by Product, 2019-2026, $ mn 36
Table 5. Global Human Insulin Drugs Market: Modern Human Insulin by Type, 2019-2026, $ mn 39
Table 6. Global Human Insulin Drugs Market: Modern Human Insulin by Brand, 2019-2026, $ mn 39
Table 7. Global Human Insulin Drugs Market: Traditional Human Insulin by Type, 2019-2026, $ mn 51
Table 8. Global Human Insulin Drugs Market: Traditional Human Insulin by Brand, 2019-2026, $ mn 51
Table 9. Global Human Insulin Delivery Devices Market by Product, 2019-2026, $ mn 58
Table 10. Global Human Insulin Delivery Devices Market: Pens by Product, 2019-2026, $ mn 61
Table 11. Global Human Insulin Market by Application, 2019-2026, $ mn 64
Table 12. Global Human Insulin Market by Distribution Channel, 2019-2026, $ mn 69
Table 13. Global Human Insulin Market by Region, 2019-2026, $ mn 75
Table 14. Leading National Human Insulin Market, 2019 and 2026, $ mn 77
Table 15. North America Human Insulin Market by Country, 2019-2026, $ mn 80
Table 16. U.S. Human Insulin Market by Product Type, 2019-2026, $ mn 83
Table 17. U.S. Human Insulin Market by Application, 2019-2026, $ mn 83
Table 18. U.S. Human Insulin Market by Distribution Channel, 2019-2026, $ mn 83
Table 19. Canada Human Insulin Market by Product Type, 2019-2026, $ mn 86
Table 20. Canada Human Insulin Market by Application, 2019-2026, $ mn 86
Table 21. Canada Human Insulin Market by Distribution Channel, 2019-2026, $ mn 86
Table 22. Europe Human Insulin Market by Country, 2019-2026, $ mn 89
Table 23. Germany Human Insulin Market by Product Type, 2019-2026, $ mn 91
Table 24. Germany Human Insulin Market by Application, 2019-2026, $ mn 91
Table 25. Germany Human Insulin Market by Distribution Channel, 2019-2026, $ mn 91
Table 26. UK Human Insulin Market by Product Type, 2019-2026, $ mn 93
Table 27. UK Human Insulin Market by Application, 2019-2026, $ mn 93
Table 28. UK Human Insulin Market by Distribution Channel, 2019-2026, $ mn 93
Table 29. France Human Insulin Market by Product Type, 2019-2026, $ mn 95
Table 30. France Human Insulin Market by Application, 2019-2026, $ mn 95
Table 31. France Human Insulin Market by Distribution Channel, 2019-2026, $ mn 95
Table 32. Spain Human Insulin Market by Product Type, 2019-2026, $ mn 97
Table 33. Spain Human Insulin Market by Application, 2019-2026, $ mn 97
Table 34. Spain Human Insulin Market by Distribution Channel, 2019-2026, $ mn 97
Table 35. Italy Human Insulin Market by Product Type, 2019-2026, $ mn 99
Table 36. Italy Human Insulin Market by Application, 2019-2026, $ mn 99
Table 37. Italy Human Insulin Market by Distribution Channel, 2019-2026, $ mn 99
Table 38. Human Insulin Market in Rest of Europe by Country, 2019-2026, $ mn 101
Table 39. APAC Human Insulin Market by Country, 2019-2026, $ mn 104
Table 40. Japan Human Insulin Market by Product Type, 2019-2026, $ mn 107
Table 41. Japan Human Insulin Market by Application, 2019-2026, $ mn 107
Table 42. Japan Human Insulin Market by Distribution Channel, 2019-2026, $ mn 107
Table 43. China Human Insulin Market by Product Type, 2019-2026, $ mn 109
Table 44. China Human Insulin Market by Application, 2019-2026, $ mn 109
Table 45. China Human Insulin Market by Distribution Channel, 2019-2026, $ mn 109
Table 46. Australia Human Insulin Market by Product Type, 2019-2026, $ mn 111
Table 47. Australia Human Insulin Market by Application, 2019-2026, $ mn 111
Table 48. Australia Human Insulin Market by Distribution Channel, 2019-2026, $ mn 111
Table 49. India Human Insulin Market by Product Type, 2019-2026, $ mn 113
Table 50. India Human Insulin Market by Application, 2019-2026, $ mn 113
Table 51. India Human Insulin Market by Distribution Channel, 2019-2026, $ mn 113
Table 52. South Korea Human Insulin Market by Product Type, 2019-2026, $ mn 115
Table 53. South Korea Human Insulin Market by Application, 2019-2026, $ mn 115
Table 54. South Korea Human Insulin Market by Distribution Channel, 2019-2026, $ mn 115
Table 55. Human Insulin Market in Rest of APAC by Country, 2019-2026, $ mn 117
Table 56. Latin America Human Insulin Market by Country, 2019-2026, $ mn 120
Table 57. Argentina Human Insulin Market by Product Type, 2019-2026, $ mn 122
Table 58. Argentina Human Insulin Market by Application, 2019-2026, $ mn 122
Table 59. Argentina Human Insulin Market by Distribution Channel, 2019-2026, $ mn 122
Table 60. Brazil Human Insulin Market by Product Type, 2019-2026, $ mn 124
Table 61. Brazil Human Insulin Market by Application, 2019-2026, $ mn 124
Table 62. Brazil Human Insulin Market by Distribution Channel, 2019-2026, $ mn 124
Table 63. Mexico Human Insulin Market by Product Type, 2019-2026, $ mn 126
Table 64. Mexico Human Insulin Market by Application, 2019-2026, $ mn 126
Table 65. Mexico Human Insulin Market by Distribution Channel, 2019-2026, $ mn 126
Table 66. RoW Human Insulin Market by Country, 2019-2026, $ mn 130
Table 67. UAE Human Insulin Market by Product Type, 2019-2026, $ mn 132
Table 68. UAE Human Insulin Market by Application, 2019-2026, $ mn 132
Table 69. UAE Human Insulin Market by Distribution Channel, 2019-2026, $ mn 132
Table 70. Saudi Arabia Human Insulin Market by Product Type, 2019-2026, $ mn 134
Table 71. Saudi Arabia Human Insulin Market by Application, 2019-2026, $ mn 134
Table 72. Saudi Arabia Human Insulin Market by Distribution Channel, 2019-2026, $ mn 134
Table 73. South Africa Human Insulin Market by Product Type, 2019-2026, $ mn 136
Table 74. South Africa Human Insulin Market by Application, 2019-2026, $ mn 136
Table 75. South Africa Human Insulin Market by Distribution Channel, 2019-2026, $ mn 136
Table 76. Global Human Insulin Market by Key Vendor, 2019, $ mn 140
Table 77. Astra Zeneca PLC: Company Snapshot 144
Table 78. Astra Zeneca PLC: Business Segmentation 144
Table 79. Astra Zeneca PLC: Product Portfolio 145
Table 80. Astra Zeneca PLC: Revenue, 2016-2018, $ mn 145
Table 81. Astra Zeneca PLC: Recent Developments 145
Table 82. Risk Evaluation for Investing in Global Market, 2019-2026 156
Table 83. Critical Success Factors and Key Takeaways 159
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT